𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer

✍ Scribed by Yuhki Koike; Chikao Miki; Yoshinaga Okugawa; Takeshi Yokoe; Yuji Toiyama; Koji Tanaka; Yasuhiro Inoue; Masato Kusunoki

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
149 KB
Volume
98
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Protein kinase C activity as marker for
Protein kinase C activity as marker for colorectal cancer
✍ Youichirou Sakanoue; Takuya Hatada; Masato Kusunoki; Hidenori Yanagi; Takehira Y πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 French βš– 436 KB

## Abstract Protein kinase C (PKC) activity was measured in normal‐appearing colonic mucosa from patients undergoing colonic resection. Comparisons were made between cases with and without colorectal cancers. PKC activity in cytosolic and particulate fractions was significantly reduced in patients

Metastasis-associated protein S100A4β€”a p
Metastasis-associated protein S100A4β€”a potential prognostic marker for colorectal cancer
✍ A.K. Hemandas; M. Salto-Tellez; S.H. Maricar; A.F.P.K. Leong; C.K. Leow πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 220 KB

Background and Objectives: Expression of S100A4, a small calcium-binding protein, in breast, oesophagus and gall bladder cancers is shown to be associated with adverse clinical outcome. We retrospectively examined the correlation of S100A4 expression and outcome in patients with colorectal cancer. M

C-reactive protein as a prognostic marke
C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer : Results from the ASCENT trial
✍ Tomasz M. Beer; Alshad S. Lalani; Stella Lee; Motomi Mori; Kristine M. Eilers; J πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 142 KB

## Abstract ## BACKGROUND. Studies of cancer risk and molecular carcinogenesis suggest a role for inflammation in cancer development and progression. The authors sought to determine whether specific blood proteins associated with inflammation predict for outcomes in men with metastatic androgen‐in

Serum hepatocyte growth factor as a prog
Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients
✍ Yuji Toiyama; Chikao Miki; Yasuhiro Inoue; Yoshinaga Okugawa; Kouji Tanaka; Masa πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 205 KB

## Abstract We previously reported that a combination of serum hepatocyte growth factor (HGF) and carcinoembryonic antigen (CEA) was useful for selecting early‐stage colorectal cancer patients with aggressive disease. The aim of the present study was to determine whether serum HGF could provide CEA

C-reactive protein and colorectal cancer
C-reactive protein and colorectal cancer risk: A systematic review of prospective studies
✍ Konstantinos K. Tsilidis; Casey Branchini; Eliseo Guallar; Kathy J. Helzlsouer; πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 French βš– 295 KB πŸ‘ 1 views

## Abstract C‐reactive protein is a sensitive but nonspecific systemic marker of inflammation. Several prospective studies have investigated the association of prediagnostic circulating C‐reactive protein concentrations with the development of colorectal cancer, but the results have been inconsiste